NCT07300514
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +11 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Clinical trial condition
Lymphoma, T-Cell, Peripheral
Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.
235 public trials
60 recruiting studies
Lymphoma, T-Cell, Peripheral trial results
NCT06519526
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
NCT07270861
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT07164560
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- 2nd Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou, Zhejiang, China
NCT07470996
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
NCT07414758
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06630091
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07389616
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT04390737
- Conditions
- Advanced Solid Tumor, Epithelioid Sarcoma, FL Lymphoma, +15 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
- NEXT Oncology San Antonio, Texas, United States
Recruiting
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
NCT06909877
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sichuan Cancer Hospital Chengdu, China